Substituted 3-phenoxy-1-alkoxycarbonylalkylamino-propanol-2-s having
申请人:E. I. du Pont de Nemours & Co.
公开号:US05051446A1
公开(公告)日:1991-09-24
The present invention relates to new compounds of the formula I ##STR1## as well as their preparation, pharmaceutical preparations containing same, and method of treating acute myocardial infarction. The compounds which possess beta-adrenoceptor blocking activity are very shortacting and are preferably intended for treatment of acute myocardial infarction by administration by means of injection.
New substituted 3-phenoxy-1-alkoxycarbonyl-alkylamino-propanol-2-s having beta receptor blocking properties
申请人:Aktiebolaget Hässle
公开号:EP0041492A1
公开(公告)日:1981-12-09
The present invention relates to new compounds of the formula
as well as their preparation, pharmaceutical preparations containing same, and method of treating acute myocardial infarction.
The compounds which possess beta-adrenoceptor blocking activity are very shortacting and are preferably intended for treatment of acute myocardial infarction by administration by means of injection.
Chelation-directed remote <i>meta</i>-C–H functionalization of aromatic aldehydes and ketones
作者:Shuguang Xie、Sen Li、Wenqian Ma、Xiaohua Xu、Zhong Jin
DOI:10.1039/c9cc05807a
日期:——
palladium-catalyzed remote meta-C–H functionalization of aromaticaldehydes and ketones. In situ-generation of acetals and ketals, as well as removal afterwards, makes the C–H bond functionalization process more straightforward and efficient. This also represents the first example of chelation-directed meta-C–H functionalization of aromaticaldehydes and ketones.